Anxiolytic effects of vestipitant in a sub-group of healthy volunteers known to be sensitive to CO2 challenge

Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals

(2013) Francesca Brambilla et al.   PSYCHONEUROENDOCRINOLOGY

Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder

(2011) Emiliangelo Ratti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Validating the inhalation of 7.5% CO2 in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD)

(2011) Jayne E Bailey et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety

(2011) Jayne E Bailey et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trial

(2010) Sanjay J. Mathew et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effects of 7.5% CO2 challenge in generalized anxiety disorder

(2010) Kate Seddon et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Genetic moderation of CO2-induced fear by 5-HTTLPR genotype

(2010) Koen Schruers et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils

(2009) Scott A. Heldt et al.   BEHAVIOURAL PHARMACOLOGY

Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders

(2009) Karl Ebner et al.   CURRENT PHARMACEUTICAL DESIGN

The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures

(2008) A. Papadopoulos et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Effect of Neurokinin1 Receptor Blockade on Territorial Aggression and in a Model of Violent Aggression

(2007) Jozsef Halasz et al.   BIOLOGICAL PSYCHIATRY